<DOC>
	<DOCNO>NCT02484573</DOCNO>
	<brief_summary>This study seek investigate whether non-selective beta blocker treatment decrease intestinal permeability cirrhotic patient alter expression gene encode intercellular junction protein .</brief_summary>
	<brief_title>Evaluation Intestinal Permeability , Expression Genes Epithelial Integrity Duodenal Wall , Serum Inflammatory Cytokines , Lipopolysaccharide Cirrhotic Patients Before After Treatment With Non-selective Beta Blocker ( Propranolol )</brief_title>
	<detailed_description>There evidence non-selective beta-blocker ( NSBB ) propranolol reduce intestinal permeability decrease bacterial translocation cirrhotic patient , independent hemodynamic effect portal pressure . The mechanism decrease intestinal permeability bacterial translocation occur establish . Among proposed mechanism : modification splanchnic hemodynamics , increase gastrointestinal motility , immunological property nonselective beta blockade . It know , however , beta-blocker treatment decrease intestinal permeability alter expression gene encode intercellular junction protein . This study seek investigate question improve understand mechanism beta-blockers work primary secondary prophylaxis variceal hemorrhage .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>&gt; 18 year Diagnosis cirrhosis etiology severity establish treat physician ( biopsy , biochemical , image ) High risk gastroesophageal varix , medium/large varix size varix red wale sign Scheduled appointment endoscopic ligation previously order treat physician Signed informed consent Ability keep return appointment Beta blocker treatment within 1 month prior study period Antibiotic treatment within 1 month prior study period Prebiotic probiotic treatment within 1 month study period Current immunosuppressive treatment Patients active infectious process Patients portal thrombosis Patients hepatocellular carcinoma Patients intestinal surgical shunt Patients chronic diarrhea document celiac disease Patients chronic renal failure ( KDOQI : â‰¤ 3 ) Patients allergy absolute contraindication use nonselective beta blocker ( asthma , significant heart block , systolic BP &lt; 90 mm Hg , basal HR &lt; 55 , refractory ascites )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cirrhosis</keyword>
	<keyword>Variceal Bleeding</keyword>
	<keyword>Non-selective beta blocker</keyword>
	<keyword>Intestinal Permeability</keyword>
	<keyword>Gene expression</keyword>
	<keyword>Bacterial translocation</keyword>
</DOC>